The civic record
Read. Follow. Verify.Pennsylvania updates pharmacy permit rules to align prescription transfer restrictions with federal regulations
Last action · March 26, 2025: Referred to CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, March 26, 2025Sponsors: Lisa Borowski and 22 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Pennsylvania HB 60 amends the to remove the specific statutory prohibition against transferring prescriptions between pharmacies, replacing it with a standard allowing any prescription transfer permitted by federal law and regulation.
Patients and pharmacies are affected by changes to prescription transfer rules, shifting the governing standard for controlled substances directly to federal guidelines and electronic prescription standards.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Pharmacies in Pennsylvania
Pharmacies must follow updated standards for transferring prescriptions between locations based on federal regulations.
Patients filling prescriptions in Pennsylvania
Patients experience updated legal parameters for transferring prescriptions, including Schedule II controlled substances, between pharmacies.
Key Facts
- Removes the explicit state-level statutory prohibition against transferring Schedule II controlled substance prescriptions between pharmacies.
- Updates pharmacy permit requirements to state that a drug is eligible for transfer unless excluded by federal law or regulation.
- Explicitly references federal rules including 21 CFR 1306.08 relating to electronic prescriptions.
- The act takes effect in 60 days.
Frequently Asked Questions
What does House Bill 60 change about transferring prescriptions?
When does this change take effect?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently passed chamber. The next step in the legislative lifecycle is Law.
Procedural history
11 actions- Mar 26, 2025SenateCommitteeReferred to CONSUMER PROTECTION AND PROFESSIONAL LICENSURE, March 26, 2025
- Mar 26, 2025SenateIn the Senate
- Mar 19, 2025HouseFloorThird consideration and final passage, March 19, 2025 (202-0)
- Mar 19, 2025HouseCommitteeRe-reported as committed, March 19, 2025
- Mar 18, 2025HouseRe-committed to APPROPRIATIONS, March 18, 2025
- Mar 18, 2025HouseFloorSecond consideration, March 18, 2025
Show 5 earlier actions
- Mar 17, 2025HouseRemoved from table, March 17, 2025
- Feb 5, 2025HouseLaid on the table, Feb. 5, 2025
- Feb 5, 2025HouseIntroducedFirst consideration, Feb. 5, 2025
- Feb 5, 2025HouseReported as amended, Feb. 5, 2025
- Jan 13, 2025HouseCommitteeReferred to HEALTH, Jan. 10, 2025
Version history & redline
2 versions on fileLobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 18 more sponsors
Connected Entities
Sources
www.palegis.us
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools